Chantal Valiquette - Concepedia

Concepedia

Author

Chantal Valiquette

McGill University ORCID

Also Known As

C. Valiquette, Chantal Valiquette, Dick Menzies

26

Publications

1.6K

Citations

13

H-Index

19

Concepts

All Affiliations

McGill University McGill University Health Centre Padjadjaran University BC Centre for Disease Control University of Alberta

CV

About

Chantal Valiquette is an author at McGill University specializing in tuberculosis prevention, medicine, and tuberculosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	910
2	Pharmacology	2	2	847
3	Health Sciences	1	1	14
4	Epidemiology	1	1	63
5	Immunology	1	1	14

Chantal Valiquette

×

12

Publications

1.6K

Citations

12

H-Index

	Year	Citations
Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis Daphne Yee, Chantal Valiquette, Marthe Pelletier, American Journal of Respiratory and Critical Care Medicine Drug SafetyCompromise TreatmentPulmonary TuberculosisActive TbTuberculosis Prevention	2003	833
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults Dick Menzies, Mênonli Adjobimey, Rovina Ruslami, New England Journal of Medicine	2018	368
Safety and Side Effects of Rifampin versus Isoniazid in Children Thierno Diallo, Mênonli Adjobimey, Rovina Ruslami, New England Journal of Medicine	2018	155
Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials Jonathon R. Campbell, Anete Trajman, Victoria J. Cook, The Lancet Infectious Diseases Drug SafetyAdverse EventsPulmonary TuberculosisTuberculosis PreventionPatient Safety	2019	63
Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trial Olivia Oxlade, Andrea Benedetti, Mênonli Adjobimey, The Lancet Public Health	2021	34
Enhancing the public health impact of latent tuberculosis infection diagnosis and treatment (ACT4): protocol for a cluster randomised trial Olivia Oxlade, Anete Trajman, Andrea Benedetti, BMJ Open	2019	21
Resource implications of the latent tuberculosis cascade of care: a time and motion study in five countries Hannah Alsdurf, Olivia Oxlade, Mênonli Adjobimey, BMC Health Services Research	2020	16
Solutions to improve the latent tuberculosis Cascade of Care in Ghana: a longitudinal impact assessment Leila Barss, Joseph Obeng, Federica Fregonese, BMC Infectious Diseases	2020	16
Serum lipids as biomarkers for therapeutic monitoring of latent tuberculosis infection Amr S. Albanna, Kenneth Bachmann, Donald B. White, European Respiratory Journal Lipid AnalysisWorld Health OrganizationTuberculosis PreventionImmunologySerum Lipids	2013	14
The mTST – An mHealth approach for training and quality assurance of tuberculin skin test administration and reading Saeedeh Moayedi-Nia, Leila Barss, Olivia Oxlade, PLoS ONE	2019	14

Page 1